Pancreatic Cancer Research

ResearcherSHOWA Medical UniversityNo recent work listed

Wataru Ichikawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5543-4488; OpenAlex author ID A5008014743. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 2 papers

Papers 4

  1. A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gem… Co-author DOI 10.1007/s00280-017-3351-4↗
  2. Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysis. Co-author DOI 10.1093/jjco/hyx075↗
  3. Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX. Co-author DOI 10.18632/oncotarget.12007↗
  4. Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer? Last author DOI 10.1111/cas.12708↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junji Furuse · 2 shared papers, 2017 · strength 0.14
  2. Takuji Okusaka · 2 shared papers, 2017 · strength 0.14
  3. Yutaro Kubota · 2 shared papers, 2015–2016 · strength 0.10
  4. Yasutsuna Sasaki · 2 shared papers, 2015–2016 · strength 0.10
  5. Tadashi Ishii · 1 shared paper, 2017 · strength 0.08
  6. Taketo Yamaguchi · 1 shared paper, 2017 · strength 0.06
  7. Young Suk Park · 1 shared paper, 2017 · strength 0.06
  8. Nobumasa Mizuno · 1 shared paper, 2017 · strength 0.06
  9. Tatsuya Ioka · 1 shared paper, 2017 · strength 0.06
  10. Hiroshi Ishii · 1 shared paper, 2017 · strength 0.06
  11. Masafumi Ikeda · 1 shared paper, 2017 · strength 0.06
  12. Do‐Youn Oh · 1 shared paper, 2017 · strength 0.06
  13. Makoto Ueno · 1 shared paper, 2017 · strength 0.06
  14. Yasuhiro Kaga · 1 shared paper, 2016 · strength 0.05
  15. Yu Sunakawa · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.